These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16298242)

  • 1. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.
    Lord A; Kalimo H; Eckman C; Zhang XQ; Lannfelt L; Nilsson LN
    Neurobiol Aging; 2006 Jan; 27(1):67-77. PubMed ID: 16298242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
    Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
    Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice.
    Shie FS; LeBoeuf RC; Jin LW
    Neuroreport; 2003 Jan; 14(1):123-9. PubMed ID: 12544843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C; Hosokawa M; McGeer PL
    Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
    Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
    Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain trauma in aged transgenic mice induces regression of established abeta deposits.
    Nakagawa Y; Reed L; Nakamura M; McIntosh TK; Smith DH; Saatman KE; Raghupathi R; Clemens J; Saido TC; Lee VM; Trojanowski JQ
    Exp Neurol; 2000 May; 163(1):244-52. PubMed ID: 10785464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein (PrPc) promotes beta-amyloid plaque formation.
    Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
    Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice.
    Seabrook TJ; Jiang L; Maier M; Lemere CA
    Glia; 2006 May; 53(7):776-82. PubMed ID: 16534778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
    Knobloch M; Konietzko U; Krebs DC; Nitsch RM
    Neurobiol Aging; 2007 Sep; 28(9):1297-306. PubMed ID: 16876915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Arctic Alzheimer mutation favors intracellular amyloid-beta production by making amyloid precursor protein less available to alpha-secretase.
    Sahlin C; Lord A; Magnusson K; Englund H; Almeida CG; Greengard P; Nyberg F; Gouras GK; Lannfelt L; Nilsson LN
    J Neurochem; 2007 May; 101(3):854-62. PubMed ID: 17448150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation.
    Cheng IH; Palop JJ; Esposito LA; Bien-Ly N; Yan F; Mucke L
    Nat Med; 2004 Nov; 10(11):1190-2. PubMed ID: 15502844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
    Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid.
    Craft JM; Watterson DM; Marks A; Van Eldik LJ
    Glia; 2005 Aug; 51(3):209-16. PubMed ID: 15810011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.